Here to listen, inform & support - For general enquiries call 01223-870008

Kidney Cancer UK News

Molecular markers to PREDICT drug response in kidney cancer patients

(ongoing until 2015)
Are you interested in taking part in a clinical trial in London investigating the use of molecular markers to predict response to sunitinib and/or everolimus? If you want to find out more, please call James Larkin on 020 7808 2132. Alternatively, please use our Contact Form and we will pass on your request. More details are available here.

Top